InDex Pharmaceuticals
About Us
About Us
Close
InDex Pharmaceuticals in brief
Business model
Corporate governance
General meetings
Nomination committee
Board of directors
Work of the board of directors
Management
Remuneration and incentive programmes
Auditors
Articles of association
Advisory Board North America
European key opinion leaders
Research & Development
Research & Development
Close
Technology platform & pipeline
Cobitolimod
Cobitolimod treatment
Interview with Emma - about living with ulcerative colitis
Scientific articles
CONDUCT
The Clinical Study CONDUCT
Study design
Presentations and interviews on CONDUCT
DiBiCol
DiBiCol Diagnostic
Information about DiBiCol
Investors
Investors
Close
Investing in InDex Pharmaceuticals
The share
Dividend and dividend policy
Shareholders
InDex Pharmaceuticals on Nasdaq First North Growth Market
Financial reports and presentations
Press releases
Subscribe
Financial calendar
Analysts
Prospectus archive
Certified Adviser
IR contact
Rights issue 2021
Media
Media
Close
Press releases
Image bank
Subscribe
Media contact
Contact
Contact
Close
IR contact
Media contact
Nasdaq First North Growth Market Certified Adviser
SVE
ENG
Media
Press releases
Image bank
Subscribe
Media contact
Media contact
Charlotte Admyre
Phone: +46 8 122 038 50
E-mail:
charlotte.admyre@indexpharma.com
